Initial Management of Acute Upper Gastrointestinal Bleeding: From Initial Evaluation up to Gastrointestinal Endoscopy
Section snippets
Epidemiology
UGIB is defined as bleeding proximal to the ligament of Treitz, to differentiate it from lower gastrointestinal bleeding involving the colon, and middle gastrointestinal bleeding involving the small intestine distal to the ligament of Treitz [1]. The annual incidence of hospitalization for acute UGIB is 1 per 1000 people in America [3]. It has a mortality of 7% to 10% [4]. The mortality has decreased only minimally during the last 30 years, despite the introduction of endoscopic therapy that
Etiology
Major and minor causes of UGIB are listed in Box 1, and the frequency distribution of the major causes are listed in Table 1[3], [10], [11]. Peptic ulcer disease (PUD) accounts for about half of all UGIB (see Table 1) [1], [7]. Major risk factors for PUD include Helicobacter pylori infection, use of nonsteroidal antiinflammatory drugs (NSAIDs) or aspirin, smoking, alcoholism, and prior history of PUD [9], [12]. Patients who bleed after admission for another problem usually have PUD [8]. One
Clinical assessment
Patients who have UGIB must be promptly and accurately clinically assessed, as described in Box 2, to provide a rational basis for key early decisions on their medical management, as enumerated in Box 3. The medical history, physical examination, and initial laboratory values are important in assessing resuscitation requirements, triage, endoscopy timing, consultation requirements, and prognostication [15].
General therapy
Patient resuscitation includes fluid administration, blood transfusion, cardiorespiratory support, and treatment of significant comorbid diseases, such as sepsis or coronary artery disease. In patients who have severe hemodynamic or pulmonary instability, EGD should be delayed until the patient is adequately resuscitated and stabilized.
Consultation and triage
All patients who have acute UGIB require gastroenterology consultation [63]. Surgical consultation is recommended for patients who have ongoing active bleeding, massive bleeding, recurrent bleeding, bleeding associated with significant abdominal pain, acute lower gastrointestinal bleeding, variceal bleeding, and abdominal findings suggestive of an acute abdomen. Cardiology consultation is recommended in patients who have chest pain, prior severe coronary artery disease, hemodynamic instability,
Endoscopy
EGD is the prime diagnostic and therapeutic tool for UGIB. It is the procedure of choice. It accurately delineates the bleeding site and determines the specific cause, it provides a rational basis for triage of patients for routine hospital admission versus ICU admission, it helps assess the need for surgery, it provides valuable prognostic information, and it can be used to apply the recently greatly expanded armamentarium of endoscopic therapy (see the article by Cappell and Friedel elsewhere
Clinical parameters to assess bleeding severity and efficacy of therapies
Endoscopic findings, particularly SRH, help predict the risk for rebleeding in patients who have PUD, the need for blood transfusions, the length of hospital stay, and the mortality [71], [72]. The endoscopic findings are combined with the clinical presentation and initial laboratory data in clinical scoring systems for risk stratification, triage, and prognostication [73], [74], [75]. Patient evaluation and assessment with simultaneous resuscitative measures and prompt EGD optimizes UGIB
Challenges and prospects
Mortality has stubbornly persisted at 7% to 10% for nonvariceal UGIB (NVUGIB), perhaps because patients are older, sicker, and on an ever-increasing regimen of drugs that affect hemostasis. PPI use has been validated in patients bleeding from high-risk PUD, but guidelines still need clarification regarding patient stratification, medication formulation, and timing of administration [56], [57]. The role of octreotide for NVUGIB requires further study. The clinical evaluation, diagnosis, and
Summary
UGIB is a relatively common, potentially life-threatening condition that requires rapid assessment of clinical presentation, rapid resuscitative measures, and appropriate medical triage. Administration of PPIs is an important adjunctive measure for NVUGIB. EGD remains the principal diagnostic, therapeutic, and prognostic modality for NVUGIB. The article by Cappell and Friedel elsewhere in this issue reviews the diagnostic and therapeutic role of EGD for NVUGIB.
References (78)
- et al.
Acute gastrointestinal bleeding
Med Clin North Am
(2000) - et al.
The frequency of peptic ulcer disease as a cause of upper-GI bleeding is exaggerated
Gastrointest Endosc
(2004) - et al.
Evaluation of the patient with gastrointestinal bleeding: an evidence based approach
Emerg Med Clin North Am
(1999) - et al.
Management of upper gastrointestinal bleeding in the patient with chronic liver disease
Med Clin North Am
(1996) - et al.
The National ASGE survey on upper gastrointestinal bleeding: 1. Study design and baseline data
Gastrointest Endosc
(1981) - et al.
Management of gastrointestinal bleeding induced by gastrointestinal endoscopy
Gastroenterol Clin North Am
(2000) Upper gastrointestinal bleeding in patients with esophageal varices: what is the most common source?
Am J Med
(1987)- et al.
The role of esophagogastroduodenoscopy in the diagnosis and management of upper gastrointestinal disorders
Med Clin North Am
(2002) - et al.
Mallory-Weiss syndrome: a study of 224 patients
Am J Surg
(1983) - et al.
Diagnosis and treatment of severe hematochezia: the role of urgent colonoscopy after purge
Gastroenterology
(1988)
Acute gastrointestinal bleeding in the intensive care unit. The intensivist's perspective
Gastroenterol Clin North Am
Myocardial infarction in critically ill patients presenting with gastrointestinal hemorrhage: retrospective analysis of risks and outcomes
Chest
Nonvariceal upper gastrointestinal bleeding
Gastrointest Endosc Clin N Am
Usefulness and validity of diagnostic nasogastric tube aspiration in patients without hematemesis
Ann Emerg Med
The uncleared fundal pool in acute upper gastrointestinal bleeding: implications and outcomes
Gastrointest Endosc
Endotracheal intubation for airway protection during endoscopy for severe upper GI hemorrhage
Gastrointest Endosc
Red blood cell transfusion in clinical practice
Lancet
Hematologic management of gastrointestinal bleeding
Gastroenterol Clin North Am
An annotated algorithmic approach to upper gastrointestinal bleeding. Standards of Practice Committee
Gastrointest Endosc
Effect of acid and pepsin on blood coagulation and platelet aggregation: a possible contributor prolonged gastroduodenal mucosal hemorrhage
Gastroenterology
Management of acute bleeding from portal hypertension
Best Pract Res Clin Gastroenterol
Safety and efficacy of esophagogastroduodenoscopy after myocardial infarction
Am J Med
Early endoscopy in upper gastrointestinal hemorrhage: association with recurrent bleeding, surgery and length of hospital stay
Gastrointest Endosc
Clinical scoring systems for determining the prognosis of gastrointestinal bleeding
Gastroenterol Clin North Am
Managing patients with acute nonvariceal upper gastrointestinal hemorrhage: development and effectiveness of a clinical care pathway
Am J Gastroenterol
A cost-effective approach to the patient with peptic ulcer bleeding
Surg Clin North Am
Acute upper gastrointestinal haemorrhage
Br Med Bull
Risk factors for gastrointestinal bleeding among older patients. Cardiovascular Health Study Investigators
J Am Geriatr Soc
Analysis of 3,294 cases of upper gastrointestinal bleeding in military medical facilities
Am J Gastroenterol
Characterization of gastrointestinal bleeding in severely ill hospitalized patients
Crit Care Med
Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population based study
Am J Gastroenterol
Canonical analysis of factors involved in the occurrence of peptic ulcers
Dig Dis Sci
Spectrum of endoscopic findings in patients with upper gastrointestinal symptoms after laparoscopic bariatric surgery
Obes Surg
BLEED: a classification to predict outcome in patients with acute upper and lower gastrointestinal hemorrhage
Crit Care Med
Upper gastrointestinal tract bleeding
Emerg Med Clin North Am
Risk of upper gastrointestinal injury and events in patients treated with cyclo-oxygenase COX-1/COX-2 nonsteroidal anti-inflammatory drugs (NSAIDs), COX-2 selective NSAIDs and gastroprotective cotherapy: an appraisal of the literature
J Clin Rheumatol
Risk of upper gastrointestinal ulcer bleeding with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations
Gut
The role of cyclooxygenase inhibitors in the gastrointestinal tract
Curr Gastroenterol Rep
Smoking and alcohol intake as risk factors for bleeding and perforated peptic ulcers: a population-based cohort study
Epidemiology
Cited by (95)
Point of Care Abdominal Ultrasound
2024, Seminars in Ultrasound, CT and MRIGastrointestinal Bleeding in COVID-19-Infected Patients
2023, Gastroenterology Clinics of North AmericaManagement of Acute Upper Gastrointestinal Bleeding in Critical Care Transport
2023, Air Medical JournalUpper Gastrointestinal Bleeding
2021, Clinics in Geriatric MedicineHow I Do It: Endovascular Management of Acute Nonvariceal Gastrointestinal Bleeding
2023, Seminars in Interventional RadiologyCharacterization of patients with digestive hemorrhage according to evaluation scales
2023, Medicina Interna de Mexico